Stock Picks From Seeking Alpha's October 2026 New Analysts

Seeking Alpha welcomed 25 new analysts in October and highlighted their stock picks and investment strategies. Their ratings ranged from Sell to Buy, with bullish theses on lululemon athletica, McDonald's, Shoe Station, and neocloud company Nebius; the article provides no performance figures or specific market impact.

Analysis

This is an attention/ sentiment item, not an earnings or fundamental catalyst: it supplies neither the analysts’ supporting evidence nor price, valuation, positioning, or forecast data. The bullish framing across LULU, MCD, SHOE, and NBIS is not a coherent sector signal; treating the names as a basket would obscure very different exposures. At most, wider visibility could marginally support near-term retail-investor interest, but there is no basis here to infer durable flows or a change in fundamentals.

The useful second-order lens is what evidence each thesis would need: LULU and SHOE require proof that demand and inventory economics support the bullish case; MCD requires evidence that traffic and pricing can sustain the case; NBIS requires independently verifiable demand, funding/capacity economics, and execution evidence. Those are diligence gates, not claims established by this article. Over 1–3 months, earnings, guidance, and company-specific operating data should dominate this weak sentiment signal. Over 6–18 months, competitive positioning and, for NBIS, capital intensity and delivery execution may matter more than analyst visibility. A contrarian takeaway is that the roundup’s uniformly positive selection may reflect editorial curation rather than broad analyst consensus; the article gives no way to measure either. No trade is justified on this item alone.

Key Decisions for Investors

• Do not initiate or size positions in LULU, MCD, SHOE, or NBIS based on this roundup; it contains no auditable estimates or evidence of a catalyst.
• Put the names on a verification watchlist: compare the underlying analyst theses with upcoming company guidance and reported operating metrics before acting.
• For NBIS, require evidence on contracted demand, capacity delivery, and funding needs before considering exposure; absent that information, avoid extrapolating a bullish narrative into a trade.
• Revisit only if independently observable results or guidance validate a thesis; falsification would include weaker-than-expected operating metrics or guidance that contradicts the cited analyst case.